Markets:

Overview

News

Currencies

International

Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

31.21 +0.35 (+1.13%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 14, 2024

Via Benzinga

HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024 ↗

May 13, 2024

HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 13, 2024

Via Benzinga

Harrow Announces First Quarter 2024 Financial Results

May 13, 2024

From Harrow, Inc.

Via Business Wire

Insiders Buying Greenwich LifeSciences And 2 Other Stocks ↗

March 25, 2024

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Via Benzinga

Harrow: Q4 Earnings Insights ↗

March 19, 2024

Via Benzinga

Earnings Preview: Harrow Health ↗

March 18, 2024

Via Benzinga

Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial

May 13, 2024

From Harrow, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024

April 25, 2024

From Harrow, Inc.

Via Business Wire

Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 25, 2024

Via Benzinga

Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying ↗

April 22, 2024

Via Benzinga

Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing

April 02, 2024

From Melt Pharmaceuticals, Inc.

Via Business Wire

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost ↗

March 20, 2024

Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding.

Via InvestorPlace

Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today? ↗

March 20, 2024

Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning.

Via InvestorPlace

Why Is Harrow (HROW) Stock Up 5% Today? ↗

March 20, 2024

Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023!

Via InvestorPlace

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2024

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 20, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!

Via InvestorPlace

Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 20, 2024

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Via Benzinga

Topics Stocks

HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023 ↗

March 19, 2024

HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Harrow Announces Fourth Quarter and Year-End 2023 Financial Results

March 19, 2024

From Harrow, Inc.

Via Business Wire

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024

March 05, 2024

From Harrow, Inc.

Via Business Wire

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products

February 15, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces New Appointments to its Board of Directors

January 29, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease

January 11, 2024

From Harrow, Inc.

Via Business Wire

Melt Pharmaceuticals Provides Corporate Update

January 03, 2024

From Melt Pharmaceuticals, Inc.

Via Business Wire

Harrow Partners with Leading Healthcare Market Access Technology Platforms

January 03, 2024

From Harrow, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.